Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.95B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.16.91.73%10%0.10.8
$1.06

Current Fair Value

43.7% downside

Overvalued by 43.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.95 Billion
Enterprise Value$34.20 Billion
Annual dividend$0.06
Dividend yield1.73%
Earnings per Share$1.26
Beta0.44
Outstanding Shares2,639,554,000

Return

Return on Equity10.25%ROE
Return on Assets4.07%
Return on Invested Capital5.49%

Valuation & Multiples

P/E Ratio16.94P/E Ratio
PEG111.57PEG
Price to Sales0.08Price to Sales
Price to Book Ratio0.08Price to Book Ratio
Enterprise Value to Revenue0.55
Enterprise Value to EBIT6.81
Enterprise Value to Net Income6
Total Debt to Enterprise1.24
Debt to Equity0.85Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 25, 2026
EPS
$0.10
Reported
Revenue
$3.00 B
Est. $1.65 B

Next Earnings Call

Expected Date
March 29, 2027
EPS Estimate
$0.05
Consensus analyst estimate
Revenue Estimate
$11.02 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

40,603 employees
CEO: Yi Liu

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercializ...

Questions & Answers